APOA5 and Stroke: Notably, rs2266788 in APOA5 modifies atorvastatin response in stroke patients [100] and exacerbates antipsychotic-induced hypertriglyceridemia in schizophrenia (SCZ) [101], underscoring its relevance in neuropsychiatric disorders.